For GLP-1 Users

---

Use of GLP-1 medications is becoming common to treat obesity. Recent reports show that 6% of the US adult population is using GLP-1 therapy and 12% are currently using it or have in the past (Reference 1). It has quickly become clear that GLP-1 patients have nutrition and exercise needs that are not being met. 

-Research is showing that GLP-1 users cut their calories so severely that nutrient deficiencies often develop. The most likely deficiencies are iron, calcium, magnesium, zinc, Vitamins A, D, E, K, B1, B12 and C (Reference 2).

-Such a dramatic reduction in calories (up to 40%) results in very rapid weight loss which contributes to muscle and bone loss. One recent trial showed that 39% of weight lost by GLP-1 users was lean body mass (Reference 3).

-Another interesting finding is that 67% of patients stop using the medication after 1 year and 85% after 2 years. This is a problem because it looks like lost weight comes back on quickly after stopping this medication (Reference 2).

Triad Nutrition And Fitness is one stop shopping to help you on your GLP-1 journey. 

-Nutrition counseling is available to ensure nutrient needs are being met while on this medication.

-Weight training is essential if you are taking a GLP-1 in order to minimize the loss of muscle and bone during the weight loss process. Triad Nutrition and Fitness provides custom designed strength training programs based on your goals and unique medical history.

-If and when you discontinue your GLP-1, Triad Nutrition and Fitness can help you keep the weight off with a personally designed diet and exercise strategy.

Contact Triad Nutrition And Fitness today to get started.

References

1) A. Montero, G. Sparks, M. Presiado et al. KFF Health Tracking Poll May 2024: The public’s use and views of GLP-1 drugs, Kaiser Family Foundation (KFF), 2021.

2) Mozaffarian D, Agarwal M, Aggarwal M et al. Nutrition priorities to support GLP-1 therapy for obesity: A joint advisory. American Journal of Clinical Nutrition 2025: 122:344-67.

3) Wilding J, Batterham R, Calanna S, et al. Once weekly Semaglutide in adults with overweight or obesity. New England Journal of Medicine 2021;384:989-1002.